InVivo Therapeutics Holdings Corp. (NVIV) EPS Estimated At $-0.13; Kayne Anderson Rudnick Investment Management Has Upped By $4.47 Million Its Nve (NVEC) Holding

April 18, 2018 - By Dolores Ford

InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) Logo

Kayne Anderson Rudnick Investment Management Llc increased Nve Corp (NVEC) stake by 7.64% reported in 2017Q4 SEC filing. Kayne Anderson Rudnick Investment Management Llc acquired 51,938 shares as Nve Corp (NVEC)’s stock declined 8.83%. The Kayne Anderson Rudnick Investment Management Llc holds 731,960 shares with $62.95M value, up from 680,022 last quarter. Nve Corp now has $399.81M valuation. The stock decreased 3.08% or $2.62 during the last trading session, reaching $82.57. About 3,118 shares traded. NVE Corporation (NASDAQ:NVEC) has declined 2.05% since April 18, 2017 and is downtrending. It has underperformed by 13.60% the S&P500.

Analysts expect InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) to report $-0.13 EPS on May, 3.They anticipate $0.07 EPS change or 35.00% from last quarter’s $-0.2 EPS. After having $-0.13 EPS previously, InVivo Therapeutics Holdings Corp.’s analysts see 0.00% EPS growth. The stock decreased 4.79% or $0.45 during the last trading session, reaching $8.95. About 15,396 shares traded. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.02% since April 18, 2017 and is downtrending. It has underperformed by 98.57% the S&P500.

Kayne Anderson Rudnick Investment Management Llc decreased Facebook Inc (NASDAQ:FB) stake by 6,827 shares to 669,163 valued at $118.08M in 2017Q4. It also reduced Nike Inc (NYSE:NKE) stake by 10,408 shares and now owns 425,626 shares. Roper Technologies (NYSE:ROP) was reduced too.

Investors sentiment increased to 1.42 in 2017 Q4. Its up 0.17, from 1.25 in 2017Q3. It is positive, as 8 investors sold NVEC shares while 25 reduced holdings. 12 funds opened positions while 35 raised stakes. 4.17 million shares or 19.01% more from 3.50 million shares in 2017Q3 were reported. California State Teachers Retirement System holds 0% or 7,566 shares. Atria Invests Limited Liability Co holds 0.01% or 2,941 shares in its portfolio. Martingale Asset Management Limited Partnership holds 0.01% in NVE Corporation (NASDAQ:NVEC) or 9,502 shares. The Maryland-based Price T Rowe Assoc Md has invested 0% in NVE Corporation (NASDAQ:NVEC). Moreover, Wedge Mgmt L LP Nc has 0.01% invested in NVE Corporation (NASDAQ:NVEC). Keybank Association Oh accumulated 0% or 3,179 shares. Granite Invest Prns Limited Company stated it has 0.1% in NVE Corporation (NASDAQ:NVEC). Comerica Bank owns 0% invested in NVE Corporation (NASDAQ:NVEC) for 5,997 shares. Pnc Fincl Group Incorporated stated it has 3,220 shares. Commercial Bank Of Ny Mellon Corporation owns 66,234 shares for 0% of their portfolio. Ontario – Canada-based Royal Bancorporation Of Canada has invested 0% in NVE Corporation (NASDAQ:NVEC). Ameriprise has invested 0% in NVE Corporation (NASDAQ:NVEC). Vanguard Incorporated has 0% invested in NVE Corporation (NASDAQ:NVEC). Manufacturers Life Insur The reported 36,499 shares stake. Meeder Asset Mngmt Inc invested in 0% or 58 shares.

InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, focus on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries . The company has market cap of $340.58 million. It is developing Neuro-Spinal Scaffold implant, an investigational bioresorbable polymer scaffold for acute SCI; and Therapeutic Trails injection program for the treatment of chronic SCI. It currently has negative earnings.

NVE Corporation (NASDAQ:NVEC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>